Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Details Narrative 1)

v3.10.0.1
STOCKHOLDERS' EQUITY (Details Narrative 1) - USD ($)
 12 Months Ended
Sep. 21, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2016
Amount of additional common stock issue   $ 80,475    
Maximum amount of common stock issue     $ 7,482,100  
Number of authorized share issue   250,000,000 500,000,000  
Number of common stock issue   7,407,254 4,299,311  
Number of blank-check preferred stock   15,000,000 15,000,000  
Preferred stock, par value (in dollars per share)   $ 0.001 $ 0.001  
Common stock, par value (in dollars per share)   $ 0.001 $ 0.001  
Warrant [Member]        
Warrant outstanding   6,075,874 4,567,672 7,160
Warrant [Member] | Maximum [Member]        
Warrant expiration year   2018    
Warrant [Member] | Minimum [Member]        
Warrant expiration year   2028    
Warrant Seven [Member]        
Warrant outstanding   4,000    
Warrant exercise price (in dollars per share)   $ 10.00    
Warrant Six [Member]        
Warrant outstanding [1]   134,000    
Warrant exercise price (in dollars per share)   $ 6.04    
Warrant Five [Member]        
Warrant outstanding [2]   213,800    
Warrant exercise price (in dollars per share)   $ 5.25    
Warrant Four [Member]        
Warrant outstanding [3]   1,675,000    
Warrant exercise price (in dollars per share)   $ 5.25    
Warrant Three [Member]        
Warrant outstanding [4]   2,539,061    
Warrant exercise price (in dollars per share)   $ 5.25    
Warrant One [Member]        
Warrant outstanding [5]   459,458    
Warrant exercise price (in dollars per share)   $ 2.00    
Warrant Two [Member]        
Warrant outstanding [6]   1,050,000    
Warrant exercise price (in dollars per share)   $ 2.34    
Blank Check Preferred Stock [Member]        
Number of blank-check preferred stock   15,000,000 15,000,000  
Second Purchase Agreement [Member] | Aspire Capital [Member]        
Number of share issued or sold   1,134,671    
Percentage of exercisable common stock   20.00%    
Amount of additional common stock issue   $ 8    
Maximum amount of common stock issue   $ 10    
Definitive Agreements [Member] | Directors And Management [Member] | Second Purchase Agreement [Member]        
Description of stock unit term Each unit consisting of one share of common stock and one common stock purchase warrant to purchase one share of Common Stock for $2.00 per share.      
Common stock, par value (in dollars per share) $ 2.00      
Definitive Agreements [Member] | Private Placement [Member] | Directors And Management [Member]        
Number of share issued or sold 459,458      
Unit price (in dollars per share) $ 1.85      
Number of common stock issue 459,458      
Description of stock unit term Each unit consisting of one share of common stock and one common stock purchase warrant to purchase one share of Common Stock for $2.00 per share.      
Common stock, par value (in dollars per share) $ 2.00      
Closing price (in dollars per share) $ 1.72      
Second Amended Note & Warrant Agreement [Member] | Warrant [Member]        
Warrant outstanding   6,075,874 4,567,672  
Second Amended Note & Warrant Agreement [Member] | Warrant [Member] | Maximum [Member]        
Warrant exercise price (in dollars per share)   $ 55    
Second Amended Note & Warrant Agreement [Member] | Warrant [Member] | Minimum [Member]        
Warrant exercise price (in dollars per share)   2.00    
Second Amended Note & Warrant Agreement [Member] | Warrant [Member] | Weighted Average [Member]        
Warrant exercise price (in dollars per share)   $ 4.53    
[1] As part of the underwritten public offering on July 19, 2017, the Company issued 134,000 common stock warrants to the underwriters as part of the services performed by them in connection with the underwritten public offering.
[2] On August 23, 2017, the Company issued 213,800 common stock warrants to underwriters as part of the overallotment attributed to the July 2017 underwritten public offering.
[3] On July 19, 2017, the Company issued 1,675,000 shares of Common Stock and accompanying Warrants to purchase up to 1,675,000 shares of Common Stock in connection with an underwritten public offering.
[4] On July 13, 2017, the Company declared a special dividend of warrants to purchase shares of the Company's common stock to record holders of Common Stock as of such date. Warrants to purchase 2,539,061 shares of Common Stock were distributed pro rata to all holders of common stock on the record date. These warrants will be exercisable (in accordance with their terms) to purchase one share of common stock, at an exercise price of $5.25 per share. The warrants will become exercisable commencing not less than 12 months following their July 27, 2017 distribution date and will expire five years thereafter.
[5] On September 21, 2018, the Company entered into definitive agreements with George C. Carpenter IV, President and Chief Executive Officer, Robin L. Smith, Chairman, as well as John Pappajohn, and Peter Unanue, each a director of the Company, and entities affiliated with Michal Votruba, a member of the Board of Directors of MYnd Analytics and Director of Life Sciences for the European-based RSJ-Gradus fund, relating to a private placement of an aggregate of 459,458 units for $1.85 per unit, with each unit consisting of one share of Common Stock and one Common Stock Purchase Warrant to purchase one share of Common Stock for $2.00 per share. The closing price per share of the Common Stock on the Nasdaq Stock Market on September 20, 2018 was $1.72 per share.
[6] On March 29, 2018, the Company sold an aggregate of 1,050,000 units for $2.00 per Unit each consisting of one share of newly-designated Series A Preferred Stock, and one warrant for $2.34 per share in a private placement to three affiliates of the Company, for gross proceeds of $2.1 million. The private placement closed on March 29, 2018. The closing price per share of the Common Stock on the Nasdaq Stock Market on March 29, 2018 was $1.19 per share.